The Expanding Clinical Application of TRK Inhibitors in Cancer Care: A Podcast Series

Download All
In this podcast series with downloadable slidesets, experts discuss the importance of testing for NTRK fusions, the use of TRK inhibitors for solid cancers, and optimal treatment strategies for patients with acquired resistance to first-generation TRK inhibitors.
George D. Demetri, MD
Alexander Drilon, MD

Podcasts

In this podcast episode, join George D. Demetri, MD, and Alexander Drilon, MD, to learn why, when, and how to test for NTRK fusions in patients with diverse solid tumors.

George D. Demetri, MD Alexander Drilon, MD Released: October 8, 2021

Download this short summary slideset based on the content from an expert CCO podcast covering TRK biology and oncogenesis, the frequency of NTRK fusions across diverse tumors, and methods for identifying NTRK fusions in the clinic.

George D. Demetri, MD Alexander Drilon, MD Released: October 8, 2021

In this podcast episode, listen to an engaging discussion between George D. Demetri, MD, and Alexander Drilon, MD, on key clinical trials leading to FDA approvals of first-generation TRK inhibitors, where these agents fit into treatment paradigms for various solid tumors, and considerations for choosing among currently available TRK inhibitors.

George D. Demetri, MD Alexander Drilon, MD Released: October 15, 2021

Download this short summary slideset based on the content from CCO podcast with experts discussing key clinical data informing FDA approvals and treatment sequencing with first-generation TRK inhibitors in NTRK fusion–positive solid tumors and ROS1-positive NSCLC.

George D. Demetri, MD Alexander Drilon, MD Released: October 15, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue